The glucocorticoid mometasone furoate is a novel FXR ligand that decreases inflammatory but not metabolic gene expression
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The glucocorticoid mometasone furoate is a novel FXR ligand that decreases inflammatory but not metabolic gene expression
Authors
Keywords
-
Journal
Scientific Reports
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-09-15
DOI
10.1038/srep14086
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Structures and mechanism for the design of highly potent glucocorticoids
- (2014) Yuanzheng He et al. CELL RESEARCH
- Bile Acid Derivatives as Ligands of the Farnesoid X Receptor: Molecular Determinants for Bile Acid Binding and Receptor Modulation
- (2014) Antimo Gioiello et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- A dysregulated acetyl/SUMO switch of FXR promotes hepatic inflammation in obesity
- (2014) D.-H. Kim et al. EMBO JOURNAL
- Glucocorticoid Repression of Inflammatory Gene Expression Shows Differential Responsiveness by Transactivation- and Transrepression-Dependent Mechanisms
- (2014) Elizabeth M. King et al. PLoS One
- Quantitative High-Throughput Profiling of Environmental Chemicals and Drugs that Modulate Farnesoid X Receptor
- (2014) Chia-Wen Hsu et al. Scientific Reports
- Anti-inflammatory and metabolic actions of FXR: Insights into molecular mechanisms
- (2012) Danielle A.A. Hollman et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Activation of bile salt nuclear receptor FXR is repressed by pro-inflammatory cytokines activating NF-κB signaling in the intestine
- (2011) Raffaella M. Gadaleta et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease
- (2011) R. M. Gadaleta et al. GUT
- Targeting inflammation using selective glucocorticoid receptor modulators
- (2010) Karolien De Bosscher et al. CURRENT OPINION IN PHARMACOLOGY
- Genome-wide interrogation of hepatic FXR reveals an asymmetric IR-1 motif and synergy with LRH-1
- (2010) Hansook Kim Chong et al. NUCLEIC ACIDS RESEARCH
- Guidelines for the management of contact dermatitis: an update
- (2009) J. Bourke et al. BRITISH JOURNAL OF DERMATOLOGY
- A Nurr1/CoREST Pathway in Microglia and Astrocytes Protects Dopaminergic Neurons from Inflammation-Induced Death
- (2009) Kaoru Saijo et al. CELL
- The Bile Acid Receptor FXR Is a Modulator of Intestinal Innate Immunity
- (2009) P. Vavassori et al. JOURNAL OF IMMUNOLOGY
- Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
- (2009) Toshiro Sato et al. NATURE
- Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation
- (2009) Philippe Lefebvre et al. PHYSIOLOGICAL REVIEWS
- A Versatile Viral System for Expression and Depletion of Proteins in Mammalian Cells
- (2009) Eric Campeau et al. PLoS One
- Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory response
- (2008) Yan-Dong Wang et al. HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now